Role of telemedicine in the management of oral anticoagulation in atrial fibrillation: a practical clinical approach

Future Cardiol. 2022 Sep;18(9):743-754. doi: 10.2217/fca-2022-0044. Epub 2022 Jul 13.


Compared with face-to-face consultations, telemedicine has many advantages, including more efficient use of healthcare resources, partial relief of the burden of care, reduced exposure to COVID-19, treatment adjustment, organization of more efficient healthcare circuits and patient empowerment. Ensuring optimal anticoagulation in atrial fibrillation patients is mandatory if we want to reduce the thromboembolic risk. Of note, telemedicine is an excellent option for the long-term management of atrial fibrillation patients. Moreover, direct oral anticoagulants may provide an added value in telemedicine (versus vitamin K antagonists), as it is not necessary to monitor anticoagulant effect or make continuous dosage adjustments. In this multidisciplinary consensus document, the role of telemedicine in anticoagulation of this population is discussed and practical recommendations are provided.

Keywords: COVID-19; anticoagulation; atrial fibrillation; direct oral anticoagulant; telemedicine; vitamin K antagonist.

Publication types

  • Review

MeSH terms

  • Administration, Oral
  • Anticoagulants
  • Atrial Fibrillation* / complications
  • Atrial Fibrillation* / drug therapy
  • COVID-19* / complications
  • Humans
  • Stroke*
  • Telemedicine*


  • Anticoagulants